Implementation of a national anti-tuberculosis drug resistance survey in Tanzania

BMC Public Health

Volumn 8, Issue , 2008, Pages

  Chonde, Timothy M ^a   Doulla, Basra ^a   Van Leth, Frank ^b,c   Mfinanga, Sayoki Gm ^d   Range, Nyagosya ^d   Lwilla, Fred ^a   Mfaume, Saidi M ^d   Van Deun, Armand ^e   Zignol, Matteo ^f   Cobelens, Frank G ^b,c   Egwaga, Saidi M ^a  

^a MINISTRY OF HEALTH AND SOCIAL WELFARE   (Tanzania)

^b KNCV TUBERCULOSIS FOUNDATION   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (Tanzania)

^e INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^f WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; CLASSIFICATION; DRUG EFFECT; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HEALTH SURVEY; HUMAN; INFECTION CONTROL; INFORMATION SYSTEM; MICROBIOLOGY; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; ORGANIZATION AND MANAGEMENT; PROGRAM DEVELOPMENT; PUBLIC HEALTH; SPUTUM; STANDARD; TANZANIA;

ANTITUBERCULAR AGENTS; COMMUNICABLE DISEASE CONTROL; DRUG RESISTANCE, BACTERIAL; HEALTH PLAN IMPLEMENTATION; HEALTH SURVEYS; HUMANS; INFORMATION MANAGEMENT; MYCOBACTERIUM TUBERCULOSIS; NATIONAL HEALTH PROGRAMS; PROGRAM DEVELOPMENT; PROGRAM EVALUATION; SPUTUM; TANZANIA; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 62449241982     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-8-427     Document Type: Article

References (15)

1. Anti-tuberculosis drug resistance in the world. Fourth global report. Geneva: World Health Organization 2008
2. Antimicrobial resistance in tuberculosis: an international perspective. PD van Helden PR Donald TC Victor HS Schaaf EG Hoal G Walzl RM Warren, Expert Rev Anti Infect Ther 2006 4 5 759 766 10.1586/14787210.4.5.759 17140353
3. Report of the meeting of the WHO Global Task Force on XDR-TB. Geneva, Switzerland: World Health Orgnization 2006
4. The Global MDR-TB & XDR-TB Response Plan. Geneva, Switzerland: World Health Organization 2007
5. M. tuberculosis genotypic diversity and drug susceptibility pattern in HIV-infected and non-HIV-infected patients in northern Tanzania. GS Kibiki B Mulder WM Dolmans JL de Beer M Boeree N Sam D van Soolingen C Sola AG van der Zanden, BMC Microbiol 2007 7 51 17540031 10.1186/1471-2180-7-51
6. An epidemiological study of tuberculosis and HIV infection in Tanzania, 1991-1993. HJ Chum RJ O'Brien TM Chonde P Graf HL Rieder, AIDS 1996 10 3 299 309 10.1097/00002030-199603000-00009 8882670
7. Impact of human immunodeficiency virus infection on the outcome of treatment and survival of tuberculosis patients in Mwanza, Tanzania. J van den Broek S Mfinanga C Moshiro R O'Brien A Mugomela M Lefi, Int J Tuberc Lung Dis 1998 2 7 547 552 9661820
8. Primary antimicrobial resistance among Mycobacterium tuberculosis isolates from HIV seropositive and HIV seronegative patients in Dar es Salaam Tanzania. W Urassa F Mugusi E Villamor G Msamanga C Moshiro R Bosch E Saathoff W Fawzi, BMC Res Notes 2008 1 58 18710511 10.1186/1756-0500-1-58
9. Interim Recommendations for the Surveillance of Drug Resistance in Tuberculosis. Geneva, Switzerland: World Health Organization 2007
10. Tuberculosis in Tanzania: a national sampling survey of drug resistance and other factors. Tubercle 1975 56 4 269 294 10.1016/0041-3879(75)90084-7 59442
11. Tuberculosis in Tanzania: a follow-up of a national sampling survey of drug resistance and other factors. Tubercle 1977 58 2 55 78 10.1016/0041- 3879(77)90032-0 69347
12. Tuberculosis in Tanzania - a national survey of newly notified cases. Tanzanian/British Medical Research Council Collaborative Study. Tubercle 1985 66 3 161 178 10.1016/0041-3879(85)90033-9 4049528
13. Comparison of sodium carbonate, cetyl-pyridinium chloride, and sodium borate for preservation of sputa for culture of Mycobacterium tuberculosis. M Bobadilla-del-Valle A Ponce-de-Leon M Kato-Maeda A Hernandez-Cruz JJ Calva-Mercado B Chavez-Mazari BA Caballero-Rivera JC Nolasco-Garcia J Sifuentes-Osornio, J Clin Microbiol 2003 41 9 4487 4488 12958303 10.1128/JCM.41.9.4487-4488.2003
14. Cetyl-pyridinium chloride is useful for isolation of Mycobacterium tuberculosis from sputa subjected to long-term storage. M Pardini F Varaine E Iona E Arzumanian F Checchi MR Oggioni G Orefici L Fattorini, J Clin Microbiol 2005 43 1 442 444 15635010 10.1128/JCM.43.1.442-444.2005
15. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. G Canetti W Fox A Khomenko HT Mahler NK Menon DA Mitchison N Rist NA Smelev, Bull World Health Organ 1969 41 1 21 43 5309084